☰

Steven D. Rhodes, Ph.D. - Publications

Affiliations: 
2013 Anatomy & Cell Biology Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Cell Biology, Biomechanics Biophysics, Molecular Biology, Evolution and Development Biology
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Flint AC, Mitchell DK, Angus SP, Smith AE, Bessler W, Jiang L, Mang H, Li X, Lu Q, Rodriguez B, Sandusky GE, Masters AR, Zhang C, Dang P, Koenig J, ... ... Rhodes SD, et al. Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37406085 DOI: 10.1158/1078-0432.CCR-22-2854  0.345
2023 Staedtke V, Topilko P, Le LQ, Grimes K, Largaespada DA, Cagan RL, Steensma MR, Stemmer-Rachamimov A, Blakeley JO, Rhodes SD, Ly I, Romo CG, Lee SY, Serra E. Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas. The Journal of Investigative Dermatology. PMID 37330719 DOI: 10.1016/j.jid.2023.01.042  0.362
2023 Cumpston EC, Rhodes SD, Yates CW. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas. Current Oncology Reports. PMID 36933171 DOI: 10.1007/s11912-023-01388-3  0.343
2020 Mund JA, Park S, Smith AE, He Y, Jiang L, Hawley E, Roberson MJ, Mitchell DK, Abu-Sultanah M, Yuan J, Bessler WK, Sandusky G, Chen S, Zhang C, Rhodes SD, et al. Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17. The Journal of Biological Chemistry. 295: 9948-9958. PMID 33685622 DOI: 10.1074/jbc.RA119.010981  0.467
2020 Ma Y, Gross AM, Dombi E, Pemov A, Choi K, Chaney K, Rhodes SD, Angus SP, Sciaky N, Clapp DW, Ratner N, Widemann BC, Rios JJ, Elefteriou F. A molecular basis for neurofibroma-associated skeletal manifestations in NF1. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32601387 DOI: 10.1038/S41436-020-0885-3  0.499
2020 Mund JA, Park SJ, Smith AE, He Y, Jiang L, Hawley E, Roberson MJ, Mitchell DK, Abu-Sultanah M, Yuan J, Bessler WK, Sandusky G, Chen S, Zhang C, Rhodes SD, et al. Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1. The Journal of Biological Chemistry. PMID 32471868 DOI: 10.1074/Jbc.Ra119.010981  0.465
2020 Armstrong AE, Rhodes SD, Smith A, Chen S, Bessler W, Ferguson MJ, Jiang L, Li X, Yuan J, Yang X, Yang FC, Robertson KA, Ingram DA, Blakeley JO, Clapp DW. Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1. Pediatric Blood & Cancer. e28372. PMID 32459399 DOI: 10.1002/pbc.28372  0.526
2019 Burks CA, Rhodes SD, Bessler WK, Chen S, Smith A, Gehlhausen JR, Hawley ET, Jiang L, Li X, Yuan J, Lu Q, Jacobsen M, Sandusky GE, Jones DR, Clapp DW, et al. Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice. Molecular Cancer Therapeutics. PMID 31527226 DOI: 10.1158/1535-7163.Mct-19-0123  0.491
2019 Rhodes SD, He Y, Smith A, Jiang L, Lu Q, Mund J, Li X, Bessler W, Qian S, Dyer W, Sandusky GE, Horvai AE, Armstrong AE, Clapp DW. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. Human Molecular Genetics. PMID 31091306 DOI: 10.1093/Hmg/Ddz095  0.47
2018 Gehlhausen JR, Hawley E, Wahle BM, He Y, Edwards D, Rhodes SD, Lajiness JD, Staser K, Chen S, Yang X, Yuan J, Li X, Jiang L, Smith A, Bessler W, et al. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas. Human Molecular Genetics. PMID 30335132 DOI: 10.1093/Hmg/Ddy361  0.518
2017 Zhou Y, He Y, Xing W, Zhang P, Shi H, Chen S, Shi J, Bai J, Rhodes SD, Zhang F, Yuan J, Yang X, Zhu X, Li Y, Hanenberg H, et al. Abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia. Haematologica. PMID 28341737 DOI: 10.3324/Haematol.2016.158717  0.588
2016 Zhang P, Xing C, Rhodes SD, He Y, Deng K, Li Z, He F, Zhu C, Nguyen L, Zhou Y, Chen S, Mohammad KS, Guise TA, Abdel-Wahab O, Xu M, et al. Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice. Stem Cell Reports. PMID 27237378 DOI: 10.1016/J.Stemcr.2016.04.013  0.596
2016 Rhodes SD, Yang FC. Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1. Current Osteoporosis Reports. 14: 10-5. PMID 26932441 DOI: 10.1007/s11914-016-0298-z  0.653
2015 Ferguson MJ, Rhodes SD, Jiang L, Li X, Yuan J, Yang X, Zhang S, Vakili ST, Territo P, Hutchins G, Yang FC, Ingram DA, Clapp DW, Chen S. Preclinical evidence for the use of sunitinib malate in the treatment of plexiform neurofibromas. Pediatric Blood & Cancer. PMID 26375012 DOI: 10.1002/Pbc.25763  0.559
2015 Zhou Y, He Y, Sharma R, Xing W, Estwick SA, Wu X, Rhodes SD, Xu M, Yang FC. Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells. International Journal of Molecular Sciences. 16: 12345-59. PMID 26039236 DOI: 10.3390/Ijms160612345  0.649
2015 Rhodes SD, Yang H, Dong R, Menon K, He Y, Li Z, Chen S, Staser KW, Jiang L, Wu X, Yang X, Peng X, Mohammad KS, Guise TA, Xu M, et al. Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 25917016 DOI: 10.1002/Jbmr.2538  0.685
2015 Wu C, Rankin EB, Castellini L, Fernandez-Alcudia J, LaGory EL, Andersen R, Rhodes SD, Wilson TL, Mohammad KS, Castillo AB, Guise TA, Schipani E, Giaccia AJ. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes & Development. 29: 817-31. PMID 25846796 DOI: 10.1101/Gad.255000.114  0.418
2015 Rhodes SD, Zhang W, Yang D, Yang H, Chen S, Wu X, Li X, Yang X, Mohammad KS, Guise TA, Bergner AL, Stevenson DA, Yang FC. Dystrophic spinal deformities in a neurofibromatosis type 1 murine model. Plos One. 10: e0119093. PMID 25786243 DOI: 10.1371/Journal.Pone.0119093  0.627
2015 Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X, Yuan J, Territo P, Hutchins G, Nalepa G, Yang FC, et al. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Human Molecular Genetics. 24: 1-8. PMID 25113746 DOI: 10.1093/Hmg/Ddu414  0.541
2014 Li Y, Xing W, He YZ, Chen S, Rhodes SD, Yuan J, Zhou Y, Shi J, Bai J, Zhang FK, Yuan WP, Cheng T, Xu MJ, Yang FC. Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice. Stem Cell Investigation. 1: 19. PMID 27358865 DOI: 10.3978/J.Issn.2306-9759.2014.10.02  0.531
2014 Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, et al. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood. 123: 541-53. PMID 24255920 DOI: 10.1182/Blood-2013-05-500272  0.578
2014 Chen MY, Rhodes SD, Clapp DW. Targeting the tumor microenvironment for the treatment of plexiform neurofibromas in patients with neurofibromatosis type 1 Neurofibromatosis: Diagnosis, Management and Clinical Outcomes. 65-78.  0.435
2014 Rhodes SD, Yang FC. Hematopoietic lineages cooperate with osteoblasts in the initiation and progression of neurofibromatosis type 1 associated skeletal deficits Neurofibromatosis: Diagnosis, Management and Clinical Outcomes. 15-44.  0.5
2013 Sharma R, Wu X, Rhodes SD, Chen S, He Y, Yuan J, Li J, Yang X, Li X, Jiang L, Kim ET, Stevenson DA, Viskochil D, Xu M, Yang FC. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Human Molecular Genetics. 22: 4818-28. PMID 23863460 DOI: 10.1093/Hmg/Ddt333  0.663
2013 Rhodes SD, Wu X, He Y, Chen S, Yang H, Staser KW, Wang J, Zhang P, Jiang C, Yokota H, Dong R, Peng X, Yang X, Murthy S, Azhar M, et al. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 2476-89. PMID 23703870 DOI: 10.1002/Jbmr.1992  0.644
2013 Staser K, Park SJ, Rhodes SD, Zeng Y, He YZ, Shew MA, Gehlhausen JR, Cerabona D, Menon K, Chen S, Sun Z, Yuan J, Ingram DA, Nalepa G, Yang FC, et al. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. The Journal of Clinical Investigation. 123: 329-34. PMID 23221339 DOI: 10.1172/Jci66167  0.611
2012 He Y, Rhodes SD, Chen S, Wu X, Yuan J, Yang X, Jiang L, Li X, Takahashi N, Xu M, Mohammad KS, Guise TA, Yang FC. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions. Plos One. 7: e46900. PMID 23144792 DOI: 10.1371/journal.pone.0046900  0.642
2012 Rhodes SD, He Y, Chen S, Yang H, Menon KM, Staser K, Yang X, Mohammad KS, Guise T, Xu M, Yang F. Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits Blood. 120: 830-830. DOI: 10.1182/Blood.V120.21.830.830  0.69
2011 Wu X, Chen S, He Y, Rhodes SD, Mohammad KS, Li X, Yang X, Jiang L, Nalepa G, Snider P, Robling AG, Clapp DW, Conway SJ, Guise TA, Yang FC. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. Plos One. 6: e24917. PMID 21980365 DOI: 10.1371/journal.pone.0024917  0.634
2011 He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park SJ, Yuan J, Yang X, Li X, Jiang L, Chen S, Yang FC. Erk1 positively regulates osteoclast differentiation and bone resorptive activity. Plos One. 6: e24780. PMID 21961044 DOI: 10.1371/journal.pone.0024780  0.584
2011 Zhang W, Rhodes SD, Zhao L, He Y, Zhang Y, Shen Y, Yang D, Wu X, Li X, Yang X, Park SJ, Chen S, Turner C, Yang FC. Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. Bone. 48: 1378-87. PMID 21439418 DOI: 10.1016/J.Bone.2011.03.760  0.65
2011 He Y, Staser K, Rhodes SD, Wu X, Zhang P, Chen S, Yang F. Erk1 Plays Critical Role in Macrophage Development Blood. 118: 517-517. DOI: 10.1182/Blood.V118.21.517.517  0.588
Show low-probability matches.